[PDF] Halting the march of painful diabetic neuropathy

Source:
International Association for the Study of Pain
Publisher:
International Association for the Study of Pain (IASP)
Publication date:
01 April 2015

Abstract

Painful diabetic neuropathy is a burden to the patient and a challenge to the physician. Despite the modest efficacy and tolerability of current pharmacotherapy, a systematic trial of suitable drugs is recommended for those with moderate or severe pain. For all patients, nonpharmacological treatment is important to reduce pain and improve functional capacity. Optimal glycemic control and treatment of cardiovascular risk factors are important ways to prevent the progression of neuropathy.